Insilico Medicine Funding History

Insilico Medicine uses generative AI for drug discovery. Its work spans target identification, molecule design and preclinical and clinical development.

Company Overview

Insilico Medicine

Healthcare

Founded 2014 · Hong Kong

Official Website

Insilico Medicine Funding Timeline

Jan 15, 2025
Series E
US$110 million
Source · en.wikipedia.org ↗
Jun 15, 2022
Series D
US$60 million
Source · prnewswire.com ↗
Jun 22, 2021
Series C
US$255 million
Led by Warburg Pincus.
Source · prnewswire.com ↗

Insilico Medicine Founding Team

Alex Zhavoronkov
Co-founder of Insilico Medicine.
Status: activeReviewed: 2026-11-04

Insilico Medicine Products

Pharma.AI
Generative AI software platform for pharmaceutical research and drug discovery.
Official Website ↗
Details and Sources
Status: activeReviewed: 2026-11-05
Sources:insilico.com